103 related articles for article (PubMed ID: 20067701)
1. HCV protease inhibitory, cytotoxic and apoptosis-inducing effects of oleanolic acid derivatives.
Ma CM; Wu XH; Masao H; Wang XJ; Kano Y
J Pharm Pharm Sci; 2009; 12(3):243-8. PubMed ID: 20067701
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, and antitumor activity of oleanolic acid derivatives.
Meng YQ; Kuai ZY; Zhan SW; Li CL; Chen HR
J Asian Nat Prod Res; 2019 Jul; 21(7):633-651. PubMed ID: 29733221
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and anti-hepatocellular carcinoma activity of novel O
Zou Y; Yan C; Liu JC; Huang ZJ; Xu JY; Zhou JP; Zhang HB; Zhang YH
Chin J Nat Med; 2017 Dec; 15(12):928-937. PubMed ID: 29329650
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and anti-HCV activity evaluation of anilinoquinoline derivatives.
Peng HK; Lin CK; Yang SY; Tseng CK; Tzeng CC; Lee JC; Yang SC
Bioorg Med Chem Lett; 2012 Jan; 22(2):1107-10. PubMed ID: 22204909
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and tumor cytotoxicity of novel amide derivatives of β-hederin.
Liu Y; Lu WX; Yan MC; Yu Y; Ikejima T; Cheng MS
Molecules; 2010 Nov; 15(11):7871-83. PubMed ID: 21060295
[TBL] [Abstract][Full Text] [Related]
6. HYBRIDS OF OLEANOLIC ACID WITH NORBORNENE-2,3-DICARBOXIMIDE-N- CARBOXYLIC ACIDS AS POTENTIAL ANTICANCER AGENTS.
Bednarczyk-Cwynar B; Ruszkowskp P; Atamanyuk D; Lesyk R; Zaprutko L
Acta Pol Pharm; 2017 May; 74(3):827-835. PubMed ID: 29513952
[TBL] [Abstract][Full Text] [Related]
7. Conjugation of Uridine with Oleanolic Acid Derivatives as Potential Antitumor Agents.
Cheng KG; Su CH; Huang JY; Liu J; Zheng YT; Chen ZF
Chem Biol Drug Des; 2016 Sep; 88(3):329-40. PubMed ID: 26990000
[TBL] [Abstract][Full Text] [Related]
8. Oleanolic Acid Derivatives as Potential Inhibitors of HIV-1 Protease.
Medina-O'Donnell M; Rivas F; Reyes-Zurita FJ; Cano-Muñoz M; Martinez A; Lupiañez JA; Parra A
J Nat Prod; 2019 Oct; 82(10):2886-2896. PubMed ID: 31617361
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of oleanolic acid dimers linked at C-28 and evaluation of anti-tumor activity.
Cheng KG; Su CH; Yang LD; Liu J; Chen ZF
Eur J Med Chem; 2015 Jan; 89():480-9. PubMed ID: 25462260
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and characterization of amino acid conjugates of oleanolic acid and their in vitro cytotoxic effect on HCC cell lines.
Mustufa MA; Hashmi IA; Manzoor S; Ahmed A; Ahmed VU; Aslam A; Ozen C; Naqvi Nu; Ozturk M; Ali FI
Pak J Pharm Sci; 2014 Sep; 27(5 Spec no):1491-6. PubMed ID: 25176231
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of oleanolic acid derivatives as antitumor agents.
Chen L; Wu JB; Lei F; Qian S; Hai L; Wu Y
J Asian Nat Prod Res; 2012; 14(4):355-63. PubMed ID: 22375874
[TBL] [Abstract][Full Text] [Related]
12. [Active components of Ligustrum lucidum inhibiting hepatitis C virus replicase activity].
Sun RN; Zhang YN; Wang J; Liu HJ; Kong LB
Yao Xue Xue Bao; 2013 Sep; 48(9):1390-6. PubMed ID: 24358771
[TBL] [Abstract][Full Text] [Related]
13. Oleanolic acid derivative Dex-OA has potent anti-tumor and anti-metastatic activity on osteosarcoma cells in vitro and in vivo.
Hua Y; Zhang Z; Li J; Li Q; Hu S; Li J; Sun M; Cai Z
Invest New Drugs; 2011 Apr; 29(2):258-65. PubMed ID: 19943081
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and cytotoxicity evaluation of oleanolic acid derivatives.
Hao J; Liu J; Wen X; Sun H
Bioorg Med Chem Lett; 2013 Apr; 23(7):2074-7. PubMed ID: 23434227
[TBL] [Abstract][Full Text] [Related]
15. Potent ketoamide inhibitors of HCV NS3 protease derived from quaternized P1 groups.
Venkatraman S; Velazquez F; Wu W; Blackman M; Madison V; Njoroge FG
Bioorg Med Chem Lett; 2010 Apr; 20(7):2151-5. PubMed ID: 20226659
[TBL] [Abstract][Full Text] [Related]
16. A library of 1,2,3-triazole-substituted oleanolic acid derivatives as anticancer agents: design, synthesis, and biological evaluation.
Wei G; Luan W; Wang S; Cui S; Li F; Liu Y; Liu Y; Cheng M
Org Biomol Chem; 2015 Feb; 13(5):1507-14. PubMed ID: 25476168
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and antiviral evaluation of a novel series of homoserine-based inhibitors of the hepatitis C virus NS3/4A serine protease.
Alexandre FR; Brandt G; Caillet C; Chaves D; Convard T; Derock M; Gloux D; Griffon Y; Lallos L; Leroy F; Liuzzi M; Loi AG; Moulat L; Musiu C; Parsy C; Rahali H; Roques V; Seifer M; Standring D; Surleraux D
Bioorg Med Chem Lett; 2015 Sep; 25(18):3984-91. PubMed ID: 26231161
[TBL] [Abstract][Full Text] [Related]
18. Resistance profiling of hepatitis C virus protease inhibitors using full-length NS3.
Dahl G; Sandström A; Akerblom E; Danielson UH
Antivir Ther; 2007; 12(5):733-40. PubMed ID: 17713156
[TBL] [Abstract][Full Text] [Related]
19. Macrocyclic inhibitors of the NS3 protease as potential therapeutic agents of hepatitis C virus infection.
Tsantrizos YS; Bolger G; Bonneau P; Cameron DR; Goudreau N; Kukolj G; LaPlante SR; Llinàs-Brunet M; Nar H; Lamarre D
Angew Chem Int Ed Engl; 2003 Mar; 42(12):1356-60. PubMed ID: 12671967
[No Abstract] [Full Text] [Related]
20. Novel hepatitis C virus protease inhibitors: thiazolidine derivatives.
Sudo K; Matsumoto Y; Matsushima M; Fujiwara M; Konno K; Shimotohno K; Shigeta S; Yokota T
Biochem Biophys Res Commun; 1997 Sep; 238(2):643-7. PubMed ID: 9299567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
